INDIAN BENCHMARK opened on a flat note
with a negative bias on account of weakness in index heavyweights like L&T,
HDFC twins and Maruti Suzuki. The market will pay close attention to the
January IIP and Feb CPI data today.
FURTHER, Havells India is
planning to raise money by listing its European subsidiary Sylvania Global on
the London Stock Exchange to fund acquisitions of brands or companies in Latin
America and Europe. Ranbaxy
Laboratories is in talks with at least two companies on sourcing ingredients
for a generic version of AstraZeneca's heartburn drug Nexium.
Trend in FII flows: The FIIs
were net buyers of Rs.1471cr in the cash segment on Tuesday while the
domestic institutional investors (DIIs) were net sellers
of Rs. 1331cr, as per the provisional figures released by the NSE.
0 Comments